These are the top stories making the headlines across The Business Magazine website today:

Oxford's Grey Wolf Therapeutics announces oversubscribed $50 million Series B

Oxford's Grey Wolf Therapeutics has successfully closed an oversubscribed $50 million Series B financing expansion, led by ICG’s Life Sciences team, to advance its innovative antigen modulation therapies for oncology and autoimmune diseases, bringing the total Series B funds raised to $99 million.

Full story here: https://thebusinessmagazine.co.uk/corporate-finance/oxfords-grey-wolf-therapeutics-announces-oversubscribed-50-million-series-b/ 

Shortage of Air Traffic Controllers at Gloucestershire Airport hits service<